{"id":37359,"date":"2023-07-18T15:04:48","date_gmt":"2023-07-18T19:04:48","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/acumen-pharmaceuticals-issues-public-offering-of-100m-in-common-stock\/"},"modified":"2023-07-18T15:04:50","modified_gmt":"2023-07-18T19:04:50","slug":"acumen-pharmaceuticals-issues-public-offering-of-100m-in-common-stock","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=37359","title":{"rendered":"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"MW-BT-CO-20230717-708279\" role=\"document\">\n<p>By Denny Jacob<\/p>\n<pre><\/pre>\n<p>Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock.<\/p>\n<p>The Charlottesville, Va., clinical-stage biopharmaceutical company said it intends to use proceeds from the offering primarily to fund the Phase 2 portion of a future, potential Phase 2\/3 trial of ACU193, to fund research and development, and for working capital and other general corporate purposes.<\/p>\n<div class=\"paywall\">\n<p>Shares edged down 6.9% to $9.05 in aftermarket trading, reversing gains made earlier in the day. The stock closed up 55% and hit a 52-week high on the heels of a strong showing by its ACU193 therapy in a Phase 1 study in early Alzheimer&#8217;s disease.<\/p>\n<pre><\/pre>\n<p>Write to Denny Jacob at denny.jacob@wsj.com<\/p>\n<pre><\/pre>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/story\/acumen-pharmaceuticals-issues-public-offering-of-100m-in-common-stock-f891a649?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Denny Jacob Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock. The Charlottesville, Va., clinical-stage biopharmaceutical company said it intends to use proceeds from the offering primarily to fund the Phase 2 portion of a future, potential Phase 2\/3 trial of ACU193, to fund [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-37359","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock | iFintechWorld<\/title>\n<meta name=\"description\" content=\"By Denny Jacob Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock. The\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=37359\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"By Denny Jacob Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock. The\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=37359\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-18T19:04:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-18T19:04:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=37359#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=37359\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock\",\"datePublished\":\"2023-07-18T19:04:48+00:00\",\"dateModified\":\"2023-07-18T19:04:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=37359\"},\"wordCount\":131,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=37359#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=37359\",\"url\":\"https:\/\/ifintechworld.com\/?p=37359\",\"name\":\"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-07-18T19:04:48+00:00\",\"dateModified\":\"2023-07-18T19:04:50+00:00\",\"description\":\"By Denny Jacob Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock. The\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=37359#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=37359\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=37359#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock | iFintechWorld","description":"By Denny Jacob Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock. The","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=37359","og_locale":"en_US","og_type":"article","og_title":"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock | iFintechWorld","og_description":"By Denny Jacob Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock. The","og_url":"https:\/\/ifintechworld.com\/?p=37359","og_site_name":"iFintechWorld","article_published_time":"2023-07-18T19:04:48+00:00","article_modified_time":"2023-07-18T19:04:50+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=37359#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=37359"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock","datePublished":"2023-07-18T19:04:48+00:00","dateModified":"2023-07-18T19:04:50+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=37359"},"wordCount":131,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=37359#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=37359","url":"https:\/\/ifintechworld.com\/?p=37359","name":"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-07-18T19:04:48+00:00","dateModified":"2023-07-18T19:04:50+00:00","description":"By Denny Jacob Acumen Pharmaceuticals on Monday said it commenced an underwritten public offering of $100 million shares of its common stock. The","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=37359#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=37359"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=37359#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Acumen Pharmaceuticals Issues Public Offering of $100M in Common Stock"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/37359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37359"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/37359\/revisions"}],"predecessor-version":[{"id":37360,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/37359\/revisions\/37360"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/1898"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}